Testing effectiveness (Phase 2)Looking for participantsNCT07644897
What this trial is testing
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma
Who this might be right for
MelanomaImmune-related Adverse EventImmune Checkpoint Inhibitor
Sun Yat-sen University 55